Dagoberto Torres García is putting his DNA extraction and PCR testing skills to use in Quebec this summer by helping to identify leafhoppers carrying harmful pathogens responsible for spreading disease affecting berry fields worldwide

Originally created as a meetup group for LGBTQ tech professionals, QueerTech is now a national organization that is seeking to gain an understanding of the lived experiences of queer folk in tech, thanks to research funded by Mitacs

A team from McGill University have designed a life-saving arm bracelet that takes the guesswork out of weight-based pediatric medication dosing, avoiding costly mistakes and allowing for safer and more efficient emergency rooms

A Montréal chemical engineer and small business owner has developed a disruptive system that converts CO2 emissions into commercial-grade potassium formate — a chemical used as de-icer in airports.

With Mitacs’s support, master’s student at Concordia University starts a business to create an innovative custom-made device that addresses uterine prolapse, a challenge faced by one in 10 women.

Montréal-based small business launches a smartwatch that measures the blood oxygen level, body temperature, and heart rate, enabling early detection of COVID-19 symptoms and support for seniors in residences.

Entrepreneur and former Mitacs intern Andrée-Ann Adam’s invention prevents gum disease, improving the health of pets’ teeth. Now her small business is on a trajectory for success thanks to increasing demand.

In the turbulent COVID-19 context, Humanitas Solutions has adapted technologies it developed after the 2010 earthquake in Haiti to help the health system counter the effects of the pandemic. Mitacs interns from five universities are helping to implement solutions to deal with the emerging second wave.

Working towards a COVID-19 vaccine, Selvaraj and Kaliamurthi use artificial intelligence and reverse vaccinology.

In many remote locations, access to medical supplies, which can make the difference between a speedy recovery and death, can be limited because of their sensitivity to temperature variations during transport.

One company that’s addressing the need for a vaccine is Medicago, a biopharmaceutical company that’s using a new manufacturing technology based on Plants and Virus-like Particles (VLP). Medicago is creating a vaccine that has the potential to promote antibody production, and unlike cell culture systems, plant systems do not require complicated growth or storage conditions.

With the goal of improving access to healthy, quality, affordable and sufficient food for the residents of Montréal’s Little Burgundy, a Mitacs-funded project humanizes innovation by developing a socially relevant autonomous shuttle bus.